Management of STEC Gastroenteritis: Is There a Role for Probiotics?

Mario Giordano, Maria Elisabetta Baldassarre, Viviana Palmieri, Diletta D. Torres, Vincenza Carbone, Luisa Santangelo, Federico Gentile, Raffaella Panza, Federica Di Mauro, Manuela Capozza, Antonio Di Mauro and Nicola Laforgia
Additional contact information
Mario Giordano: Pediatric Nephrology and Dialysis Unit, Pediatric Hospital “Giovanni XXIII”, Bari 70123, Italy
Maria Elisabetta Baldassarre: Neonatology and Neonatal Intensive Care Unit, Department of Biomedical Science and Human Oncology, “Aldo Moro” University of Bari, Bari 70124, Italy
Viviana Palmieri: Neonatology and Neonatal Intensive Care Unit, Department of Biomedical Science and Human Oncology, “Aldo Moro” University of Bari, Bari 70124, Italy
Diletta D. Torres: Pediatric Nephrology and Dialysis Unit, Pediatric Hospital “Giovanni XXIII”, Bari 70123, Italy
Vincenza Carbone: Pediatric Nephrology and Dialysis Unit, Pediatric Hospital “Giovanni XXIII”, Bari 70123, Italy
Luisa Santangelo: Pediatric Nephrology and Dialysis Unit, Pediatric Hospital “Giovanni XXIII”, Bari 70123, Italy
Federico Gentile: Pediatric Nephrology and Dialysis Unit, Pediatric Hospital “Giovanni XXIII”, Bari 70123, Italy
Raffaella Panza: Neonatology and Neonatal Intensive Care Unit, Department of Biomedical Science and Human Oncology, “Aldo Moro” University of Bari, Bari 70124, Italy
Federica Di Mauro: Department of Public Health, University of Naples Federico II, Napoli 80138, Italy
Manuela Capozza: Neonatology and Neonatal Intensive Care Unit, Department of Biomedical Science and Human Oncology, “Aldo Moro” University of Bari, Bari 70124, Italy
Antonio Di Mauro: Neonatology and Neonatal Intensive Care Unit, Department of Biomedical Science and Human Oncology, “Aldo Moro” University of Bari, Bari 70124, Italy
Nicola Laforgia: Neonatology and Neonatal Intensive Care Unit, Department of Biomedical Science and Human Oncology, “Aldo Moro” University of Bari, Bari 70124, Italy

IJERPH, 2019, vol. 16, issue 9, 1-8

Abstract: Shiga toxin-producing Escherichia Coli (STEC) infections routinely run as a common gastroenteritis, but in many cases they may evolve towards hemolytic uremic syndrome (HUS). HUS is a rare disease characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. Gut microorganisms have a fundamental impact on human physiology, because they modulate normal intestinal functions and play a pivotal role in influencing the local and systemic immune responses. Despite surveillance established in many countries and major progresses in the understanding of STEC-HUS mechanisms, no specific treatment is currently available. Targeting the gut microbiota could represent a new potential therapeutic strategy in STEC infection. In this paper, we reviewed the current knowledge about microbiota characteristics of patients with STEC infections, as well as in vitro and in vivo evidence of probiotic supplementation in managing STEC gastroenteritis and in HUS onset prevention.

Keywords: “Shiga-Toxigenic Escherichia coli ” [Mesh]; “Probiotics” [Mesh]; “Microbiota” [Mesh]; “Hemolytic-Uremic Syndrome” [Mesh] (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2019
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/16/9/1649/pdf (application/pdf)
https://www.mdpi.com/1660-4601/16/9/1649/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:16:y:2019:i:9:p:1649-:d:230406

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().